• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人β3 - 肾上腺素能受体mRNA的组织分布

Tissue distribution of beta 3-adrenergic receptor mRNA in man.

作者信息

Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg A D, Ricquier D, Emorine L J

机构信息

Centre National de la Recherche Scientifíque-Unité Propre de Recherche 0415, Paris, France.

出版信息

J Clin Invest. 1993 Jan;91(1):344-9. doi: 10.1172/JCI116191.

DOI:10.1172/JCI116191
PMID:8380813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC330032/
Abstract

Expression of mRNA for beta 1-, beta 2-, and beta 3-adrenergic receptors (beta 1-, beta 2-, and beta 3-AR) was investigated in human tissues. beta 1- and beta 2-AR mRNA distribution correlated with that of the cognate receptors established by pharmacological studies. beta 3-AR transcripts were abundant in infant perirenal brown adipose tissue, characterized by the presence of uncoupling protein (UCP) mRNA. In adult whole adipose tissues, beta 3-AR mRNA levels were high in deep deposits such as perirenal and omental, and lower in subcutaneous. In these deposits, UCP mRNA levels paralleled those of beta 3-AR. However, isolated omental and subcutaneous adipose cells, enriched in white adipocytes, expressed beta 3-AR but no UCP transcripts. beta 3-AR mRNA was highly expressed in gallbladder, and to a much lower extent in colon, independently of UCP mRNA. Quadriceps or abdominal muscles, heart, liver, lung, kidney, thyroid, and lymphocytes did not express intrinsic beta 3-AR mRNA. This study demonstrates that substantial amounts of brown adipocytes exist throughout life in adipose deposits, which are generally classified as white. These deposits are the main sites of beta 3-AR expression, which also occurs in gallbladder and colon. beta 3-AR may thus be involved in the control of lipid metabolism, possibly from fat assimilation in the digestive tract, to triglyceride storage and mobilization in adipose tissues.

摘要

在人体组织中研究了β1-、β2-和β3-肾上腺素能受体(β1-、β2-和β3-AR)的mRNA表达。β1-和β2-AR mRNA的分布与药理学研究所确定的同源受体的分布相关。β3-AR转录本在婴儿肾周棕色脂肪组织中丰富,其特征是存在解偶联蛋白(UCP)mRNA。在成人全脂肪组织中,β3-AR mRNA水平在肾周和网膜等深部脂肪沉积中较高,而在皮下脂肪中较低。在这些脂肪沉积中,UCP mRNA水平与β3-AR的水平平行。然而,富含白色脂肪细胞的分离的网膜和皮下脂肪细胞表达β3-AR,但不表达UCP转录本。β3-AR mRNA在胆囊中高表达,在结肠中表达程度低得多,与UCP mRNA无关。股四头肌或腹肌、心脏、肝脏、肺、肾脏、甲状腺和淋巴细胞不表达内源性β3-AR mRNA。本研究表明,在通常被归类为白色的脂肪沉积中,终生存在大量棕色脂肪细胞。这些脂肪沉积是β3-AR表达的主要部位,β3-AR也在胆囊和结肠中表达。因此,β3-AR可能参与脂质代谢的调控,可能从消化道的脂肪吸收,到脂肪组织中甘油三酯的储存和动员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/d716a3c548b4/jcinvest00489-0361-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/b50b1f49863a/jcinvest00489-0359-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/b94f06c9d604/jcinvest00489-0360-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/4c730faa92e3/jcinvest00489-0360-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/d716a3c548b4/jcinvest00489-0361-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/b50b1f49863a/jcinvest00489-0359-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/b94f06c9d604/jcinvest00489-0360-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/4c730faa92e3/jcinvest00489-0360-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe2c/330032/d716a3c548b4/jcinvest00489-0361-a.jpg

相似文献

1
Tissue distribution of beta 3-adrenergic receptor mRNA in man.人β3 - 肾上腺素能受体mRNA的组织分布
J Clin Invest. 1993 Jan;91(1):344-9. doi: 10.1172/JCI116191.
2
Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human.成年人体内脂肪组织及其他代谢组织中β3 - 肾上腺素能受体信使核糖核酸表达缺失。
Mol Pharmacol. 1993 Mar;43(3):343-8.
3
Evidence for numerous brown adipocytes lacking functional beta 3-adrenoceptors in fat pads from nonhuman primates.在非人类灵长类动物的脂肪垫中存在大量缺乏功能性β3-肾上腺素能受体的褐色脂肪细胞的证据。
J Clin Endocrinol Metab. 1996 Jan;81(1):368-75. doi: 10.1210/jcem.81.1.8550779.
4
Expression of beta 3-adrenoceptor mRNA in rat tissues.大鼠组织中β3-肾上腺素能受体mRNA的表达。
Br J Pharmacol. 1996 Jan;117(1):210-6. doi: 10.1111/j.1476-5381.1996.tb15176.x.
5
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure.通过定量聚合酶链反应分析人心室活检标本中的β-肾上腺素能受体mRNA水平:心力衰竭时β1-肾上腺素能受体mRNA逐渐减少。
J Am Coll Cardiol. 1996 Jan;27(1):146-54. doi: 10.1016/0735-1097(95)00425-4.
6
Beta-adrenergic receptor subtype transcripts in porcine adipose tissue.猪脂肪组织中的β-肾上腺素能受体亚型转录本
J Anim Sci. 1995 Jul;73(7):1962-71. doi: 10.2527/1995.7371962x.
7
Gender effects on adrenergic receptor expression and lipolysis in white adipose tissue of rats.性别对大鼠白色脂肪组织中肾上腺素能受体表达及脂肪分解的影响。
Obes Res. 2002 Apr;10(4):296-305. doi: 10.1038/oby.2002.41.
8
Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes.棕色脂肪细胞中β-肾上腺素能受体亚型β1、β2和β3基因表达的差异肾上腺素能调节
Biochem J. 2000 May 1;347 Pt 3(Pt 3):643-51.
9
Lipoprotein lipase steady-state mRNA levels are lower in human omental versus subcutaneous abdominal adipose tissue.在人类网膜脂肪组织与腹部皮下脂肪组织中,脂蛋白脂肪酶的稳态mRNA水平较低。
Metabolism. 2000 Sep;49(9):1224-7. doi: 10.1053/meta.2000.8624.
10
Beta-adrenoceptor expression in human fat cells from different regions.不同区域人体脂肪细胞中的β-肾上腺素能受体表达
J Clin Invest. 1990 Nov;86(5):1595-600. doi: 10.1172/JCI114880.

引用本文的文献

1
Sympathetic activation of white adipose tissue recruits neutrophils to limit energy expenditure.白色脂肪组织的交感神经激活募集嗜中性粒细胞以限制能量消耗。
Res Sq. 2025 Apr 16:rs.3.rs-6414640. doi: 10.21203/rs.3.rs-6414640/v1.
2
Neuroimmune Interactions and Their Role in Immune Cell Trafficking in Cardiovascular Diseases and Cancer.神经免疫相互作用及其在心血管疾病和癌症中免疫细胞运输中的作用。
Int J Mol Sci. 2025 Mar 12;26(6):2553. doi: 10.3390/ijms26062553.
3
Effects of rapid weight loss on the body composition and pathophysiological mechanisms involved in obesity.

本文引用的文献

1
Ultrastructural and biochemical characterization of human brown adipose tissue in pheochromocytoma.嗜铬细胞瘤患者棕色脂肪组织的超微结构及生化特征
J Clin Endocrinol Metab. 1982 Apr;54(4):803-7. doi: 10.1210/jcem-54-4-803.
2
Thermogenic mechanisms in brown fat.棕色脂肪中的产热机制。
Physiol Rev. 1984 Jan;64(1):1-64. doi: 10.1152/physrev.1984.64.1.1.
3
Noradrenaline controls the concentration of the uncoupling protein in brown adipose tissue.去甲肾上腺素控制着棕色脂肪组织中解偶联蛋白的浓度。
快速减重对肥胖相关身体成分及病理生理机制的影响。
Endocr J. 2025 Mar 3;72(3):307-317. doi: 10.1507/endocrj.EJ24-0315. Epub 2024 Nov 28.
4
Association between rs4994 variant in β3-Adrenergic receptor and obesity in Vietnamese preschool-age children, independent of eating behaviors.β3-肾上腺素能受体 rs4994 变异与越南学龄前儿童肥胖的相关性,与饮食行为无关。
BMC Pediatr. 2024 Sep 18;24(1):594. doi: 10.1186/s12887-024-05073-7.
5
Physiological and metabolic functions of the β-adrenergic receptor and an approach to therapeutic achievements.β-肾上腺素能受体的生理和代谢功能及治疗成果的实现途径。
J Physiol Biochem. 2024 Nov;80(4):757-774. doi: 10.1007/s13105-024-01040-z. Epub 2024 Aug 15.
6
Weighing in on the role of brown adipose tissue for treatment of obesity.探讨棕色脂肪组织在肥胖治疗中的作用。
J Pharm Pharm Sci. 2024 Jul 17;27:13157. doi: 10.3389/jpps.2024.13157. eCollection 2024.
7
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis.新型拟交感神经胺激动剂 ATR-127 靶向骨骼肌和棕色脂肪组织,以解决糖尿病肥胖和脂肪性肝炎。
Mol Metab. 2024 Jul;85:101931. doi: 10.1016/j.molmet.2024.101931. Epub 2024 May 17.
8
Inside the Biology of the β3-Adrenoceptor.β3-肾上腺素能受体的生物学特性
Biomolecules. 2024 Jan 29;14(2):159. doi: 10.3390/biom14020159.
9
Is the β-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?β-肾上腺素受体是否是肥胖症和/或 2 型糖尿病治疗的有效靶点?
Biomolecules. 2023 Nov 28;13(12):1714. doi: 10.3390/biom13121714.
10
Beta-Adrenergic Agonists, Dietary Protein, and Rumen Bacterial Community Interactions in Beef Cattle: A Review.肉牛中β-肾上腺素能激动剂、膳食蛋白质与瘤胃细菌群落的相互作用:综述
Vet Sci. 2023 Sep 18;10(9):579. doi: 10.3390/vetsci10090579.
FEBS Lett. 1984 Jan 30;166(2):393-6. doi: 10.1016/0014-5793(84)80120-9.
4
Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes.一种推定的肾上腺素能受体的激动剂和拮抗剂特性,其具有与α和β亚型不同的药理学特性。
Br J Pharmacol. 1988 Nov;95(3):723-34. doi: 10.1111/j.1476-5381.1988.tb11698.x.
5
Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.人类脂肪细胞β-肾上腺素能受体:β-激动剂依赖性脂解反应以及用高选择性β1拮抗剂对人脂肪细胞膜上β-肾上腺素能结合位点的特性研究
J Lipid Res. 1988 May;29(5):587-601.
6
The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity.新型β-肾上腺素能受体激动剂BRL 26830A对难治性肥胖的影响。
Int J Obes. 1988;12(2):119-23.
7
Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical beta adrenoceptor agonist.给予新型非典型β肾上腺素能受体激动剂BRL 26830A的肥胖受试者在限制饮食时的体重减轻情况。
Br Med J (Clin Res Ed). 1988 Apr 30;296(6631):1217-20. doi: 10.1136/bmj.296.6631.1217.
8
Thermogenic effect of the new beta-adrenoreceptor agonist Ro 16-8714 in healthy male volunteers.新型β-肾上腺素能受体激动剂Ro 16-8714对健康男性志愿者的产热效应。
Int J Obes. 1987;11(5):473-83.
9
Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells.胰岛素对离体人脂肪细胞中肾上腺素能受体结合及儿茶酚胺诱导的脂解速率的影响。
J Biol Chem. 1988 Oct 25;263(30):15553-60.
10
An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle.对介导大鼠比目鱼肌对新型激动剂BRL28410代谢反应的β-肾上腺素能受体的研究。
Biochem Pharmacol. 1988 Mar 1;37(5):947-50. doi: 10.1016/0006-2952(88)90186-4.